Cryoport (CYRX)
Runs cryogenic logistics, biostorage, and equipment for life-sciences materials.
$17.22
vs last close−0.35 (−1.99%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 56 | 57 | 37 | 40 | 57 | 60 | 41 | 45 | 44 | 45 | 48 | 49 |
| Cost of revenue | 32 | 34 | 22 | 22 | 31 | 32 | 22 | 24 | 23 | 24 | 26 | 26 |
| Gross profit | 24 | 23 | 15 | 18 | 25 | 27 | 19 | 21 | 21 | 22 | 22 | 23 |
| 41 | 93 | 33 | 96 | 42 | 41 | 28 | 31 | 31 | 32 | 32 | 33 | |
| Research & development | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 5 | 4 | 4 | 5 |
| 36 | 39 | 28 | 27 | 38 | 37 | 24 | 27 | 27 | 27 | 28 | 28 | |
| General & administrative | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28 |
| Other expenses | 0 | 50 | 0 | 64 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income | −17 | −70 | −18 | −78 | −16 | −14 | −9 | −10 | −10 | −10 | −10 | −10 |
| 4 | 6 | 3 | 2 | 18 | −5 | 1 | −2 | 3 | 3 | 0 | 2 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 3 |
| Interest expense | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 |
| Other non-operating income | −5 | −7 | −4 | −3 | −19 | 4 | −1 | 1 | −4 | −3 | −1 | −3 |
| Income before tax | −13 | −64 | −15 | −76 | 1 | −19 | −9 | −12 | −7 | −7 | −9 | −8 |
| Income tax expense | 0 | −1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
| Net income from continuing operations | −13 | −62 | −15 | −76 | 1 | −19 | −9 | −12 | −7 | −9 | −9 | −8 |
| Discontinued operations | 0 | 0 | −4 | −2 | 0 | 0 | −3 | 117 | 0 | −3 | 0 | 0 |
| Net income | −13 | −62 | −19 | −78 | 1 | −19 | −12 | 105 | −7 | −12 | −9 | −8 |
| EPS, basic | −$0.31 | −$1.31 | −$0.43 | −$1.62 | −$0.02 | −$0.42 | −$0.28 | $2.05 | −$0.18 | −$0.21 | −$0.23 | −$0.20 |
| EPS, diluted | −$0.31 | −$1.31 | −$0.43 | −$1.62 | −$0.02 | −$0.42 | −$0.28 | $2.05 | −$0.18 | −$0.21 | −$0.23 | −$0.20 |
| Weighted average shares, basic | 49 | 49 | 49 | 49 | 49 | 50 | 50 | 50 | 50 | 50 | 50 | 50 |
| Weighted average shares, diluted | 49 | 49 | 49 | 49 | 49 | 50 | 50 | 50 | 50 | 50 | 50 | 50 |
| EBITDA | −5 | −55 | −6 | −68 | 10 | −10 | −1 | −4 | 0 | 0 | −2 | −1 |
| Depreciation & amortization | 7 | 7 | 7 | 8 | 8 | 8 | 8 | 7 | 6 | 6 | 6 | 7 |
| EBIT | −11 | −62 | −14 | −75 | 2 | −18 | −8 | −11 | −6 | −7 | −9 | −7 |
